Global Health reveals a possible link between heart inflammation and anti-Covid 19 vaccines

Geneva-Sana

The World Health Organization has revealed a possible link between cases of inflammation in the heart and vaccines that use the same technology as the messenger RNA (RNA) against Covid-19.

And Agence France-Presse quoted experts from the WHO’s Vaccine Safety Advisory Committee as saying in a statement yesterday that “cases of myocarditis and pericarditis have been reported in many countries, especially in the United States,” noting that the reported cases occurred in the past few days. That followed vaccination and more in young people, especially after the second dose of the messenger RNA vaccine against Covid 19.

After reviewing the available information, the experts concluded that the current data indicate a possible causal link between myocarditis and messenger RNA vaccines, explaining that the benefits of messenger RNA vaccines outweigh the risks in reducing hospitalizations and deaths caused by infection with Covid 19.

The experts of the World Health Organization pointed out that the available data indicate that the incidence of myocarditis and pericarditis after vaccination is generally mild.

On June 23, the US health authorities announced a possible link between vaccines against Covid 19 from the Pfizer and Moderna vaccines, and rare cases of heart infections in adolescents and young adults.

The European Medicines Agency's Committee on Risk Assessment and Pharmacovigilance, at its meeting held between July 5-8, examined the latest data from Europe and confirmed the existence of a reasonable causal relationship between myocarditis and vaccines with messenger RNA technology, according to the World Health Organization.

Myocarditis is a rare disease that experts believe is usually caused by a virus. Its most common symptom is chest pain, and is often treated with anti-inflammatory drugs or, if necessary, oxygen support.